Results: 24 news stories
Researchers uncover potential strategy for safer cancer treatments
Scientists at The University of Texas at San Antonio discovered a potential path to maintaining the cancer-fighting benefits of one type of immunotherapy while limiting harmful organ damage, providing new hope for this promising treatment.
UT Health San Antonio researcher receives $400,000 Komen grant to study therapeutic yoga for breast cancer survivors
Amelie G. Ramirez, DrPH, MPH, to work with Hispanics in South Texas Content provided by Cliff Despres Amelie G. Ramirez, DrPH, MPH, a cancer researcher at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, is receiving a two-year, $400,000 leadership grant from Susan G. Komen to study cancer survivorship. She aims […]
GLP-1 and reduced cancer risk discovery earns UT Health San Antonio fellow prestigious Helio NextGen Disruptor Award
Colton Frisco Jones, MD, a 2nd-year fellow at the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio NextGen Disruptor Award at the American Society of Clinical Oncology (ASCO) 2026 annual […]
Researcher awarded $4.6 million to study DNA repair, cancer biology
A scientist at The University of Texas at San Antonio was recently awarded two grants totaling more than $4.6 million from the National Institutes of Health to study how cells repair DNA to protect the genome, the set of genetic instructions within our cells.
UT San Antonio MD/PhD graduate student earns top NIH ranking for research proposal
A third-year MD/PhD graduate student from The University of Texas at San Antonio (UT San Antonio), Christopher Mullally, recently received funding from the National Institutes of Health National Cancer Institute for a project examining how the body regulates internal sources of mutation and how breakdowns in that regulation may contribute to cancer development. While […]
San Antonio Business Journal: UT San Antonio lands millions in new state funding
San Antonio Report: UT San Antonio lands millions in new state funding
CPRIT awards newly integrated UT San Antonio to further its mission to combat cancers across South Texas
The University of Texas at San Antonio and its academic health center, UT Health San Antonio, recently received over $2.7 million in new academic and prevention awards from the Cancer Prevention and Research Institute of Texas (CPRIT) to further its mission of combating cancers across South Texas. Since 2010, CPRIT has awarded the newly integrated UT San Antonio almost $186 million.
UT Health San Antonio researcher awarded $2.1M award to study cellular structures
Like a busy restaurant kitchen, our cells depend on well-organized working spaces to assemble the “recipes” that keep the body healthy. UT San Antonio scientist, David Libich, PhD, recently received a five-year, $2.1 million Maximizing Investigators’ Research Award from the National Institute of General Medical Sciences to study how certain proteins form these organizational hubs and what happens when things do not go according to plan.
Drug shows promise for halting chronic pain before it starts
Scientists at The University of Texas at San Antonio (UT San Antonio) are investigating a major immune system pathway that leads to the development of chronic pain and a drug that has the potential to stop the process in its tracks. Their study, published April 22 in Cell Reports, is the first of its kind to show a path toward the prevention of chronic pain.
UT San Antonio-led cancer research program could revolutionize treatment
Written by: Claire Kowalick More than 70% of cancers — including breast, bladder, cervical and lung cancer — show evidence of mutations linked to a group of enzymes called apolipoprotein B mRNA-editing enzyme catalytic polypeptides, or APOBEC. “APOBEC mutagenesis is the second-largest source of mutation in cancer and, importantly, the largest one we can do […]
New study aims to guide prostate cancer patients through early treatment decisions
For more than 20 years, Lixin Song, PhD, RN, FAAN, vice dean for research and scholarship and professor of nursing at The University of Texas at San Antonio (UT San Antonio) School of Nursing, has studied how cancer patients and their families navigate the challenging experience of making decisions about treatment while facing uncertainty, […]
UT Health San Antonio Multispecialty and Research Hospital treats first clinical trial participant in novel cancer study
UT Health San Antonio Multispecialty and Research Hospital has enrolled and treated its first clinical trial participant in a novel cancer study, marking a pivotal moment for science and patient-centered cancer care in San Antonio and South Texas.
Widely used metabolic drugs may help curb rising colorectal cancer in younger adults
A large, retrospective study conducted by scientists at the University of Texas at San Antonio (UT San Antonio) suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists — medications that are widely prescribed for metabolic disease — have a significantly lower risk of developing colorectal cancer compared with those taking aspirin. “This is astounding to […]
Robotic surgery on forefront of HPV-related cancer treatment
This story was first published in the February 2026 issue of the Bexar County Medical Society’s San Antonio Medicine magazine. New face of head and neck cancer A healthy 40-year-old man visits his primary care physician for a mass on his neck. He doesn’t smoke, has no risk factors for head and neck cancer, […]
UT Health San Antonio awarded $3 million CPRIT grant to bolster cancer research and prevention efforts in South Texas
UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), received nearly $3 million in new academic and prevention awards as part of the latest, almost $154 million funding round announced on November 19 by the Cancer Prevention Research Institute of Texas (CPRIT). This brings CPRIT’s […]
UT San Antonio advances detection, prevention of hidden stomach infections linked to cancer
Research scientists and clinicians at UT Health San Antonio are working to halt one of the most persistent bacterial infections that silently affects millions of people worldwide. Helicobacter pylori (H. pylori) is a spiral-shaped bacterium capable of burrowing into the stomach lining and is the only bacterium known to directly cause cancer. Through leading […]
Gastrointestinal cancer rising sharply in younger adults
UT Health San Antonio’s advanced endoscopy team leads efforts in early detection and prevention Gastrointestinal cancers were previously believed to primarily affect older adults, but over the past two decades, rates of these cancers have increased dramatically in people under age 50. A new report from the Dana-Farber Cancer Institute reveals that colorectal, pancreatic, esophageal […]
Collaborative research program aims to revolutionize cancer treatment
More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung. The University of Texas […]
New study maps protein structure involved in DNA repair, cancer pathways
When a protein is modified inside the cell, it can change how that protein works, either by turning on or shutting off vital functions. One important system that controls these changes is called the small ubiquitin-like modifier, or SUMO, pathway, which affects many actions including DNA repair and stress response. Scientists at The University […]
The potency of compound thinking
University researchers have developed a promising compound that targets tumor cells while sparing healthy tissue. Their collaboration shows the power of multidisciplinary science that bridges dentistry, chemistry and commercialization to bring hope to patients.